TITLE

Chemotherapy in breast cancer

PUB. DATE
October 1976
SOURCE
British Medical Journal;10/9/1976, Vol. 2 Issue 6040, p832
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Examines the reaction of the media on the coverage of using adjuvant chemotherapy in breast cancer. Status of adjuvant chemotherapy in early breast cancer; Types of drugs in the treatment of cancer contributing the risk of developing other cancers; Properties of drugs.
ACCESSION #
4932479

 

Related Articles

  • Adjuvant chemotherapy for breast cancer: side effects and quality of life. Palmer, B.V.; Walsh, G.A.; McKinna, J.A.; Greening, W.P. // British Medical Journal;12/13/1980, Vol. 281 Issue 6255, p1594 

    Examines the adjuvant chemotherapy for breast cancer in Great Britain. Six-month course of five-drug combination of chlorambucil, methotrexate, fluorouracil, vincristine, and adriamycin treatment for post operative chemotherapy; Interference of side effects on the lifestyle of patients and of...

  • Routine zoledronic acid use not supported in early breast cancer. McSweeny, Linda // Medical Journal of Australia;10/17/2011, Vol. 195 Issue 8, p439 

    The article focuses on an open-label phase three randomised trial which suggests that the routine zoledronic acid use in the adjuvant treatment of early-stage breast cancer is not supported.

  • A surgical subculture. Starreveld, Adalei // CMAJ: Canadian Medical Association Journal;01/01/97, Vol. 156 Issue 1, p43 

    Editorial. Comments on the inconsistent results of the studies on the use of the breast-conserving surgery to treat breast cancer. Limited role of adjuvant treatment in reducing the rates of local recurrence; Lack of consistency in the extent of surgery and radiation therapy. Suggestions for...

  • Radiation oncology.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS91 

    Presents an abstract of the research manuscript `Is 4000 cGY in 16 fractions adequate for local control in the adjuvant treatment of early breast cancer?,' by J. Yamada et al.

  • Medical oncology.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS60 

    Presents an abstract of the research manuscript `Changes in physical performance during adjuvant chemotherapy for breast cancer in postmenopausal women,' by J.M. Watters et al.

  • CORRESPONDENCE. Marcus, Richard; Holland, James; Green, A.; Hamblin, Terry J.; Morrison, J.M.; Monypenny, I.J.; Arkell, D.G.; Ryan, B.J.; Senapati, Asha; Stevenson, David; Pilsworth, Roy; Peters, J.L.; Fisher, C.; Mehtar, S.; Swift, C.; Malhotra, S.L.; Murray, Elizabeth D.S.; Hughes-Davies, T.H. // British Medical Journal (Clinical Research Edition);1/17/1981, Vol. 282 Issue 6259, p220 

    Comments on several issues related to medicine in Great Britain. Initiative to breast cancer trials; Side effects of adjuvant therapy for breast cancer; Decline of high density lipoprotein cholesterol concentrations in people with a high dietary sugar.

  • Adjuvant Therapy for Women Over Age 65 With Breast Cancer. Sautter-Bihl, Marie-Luise; Souchon, Rainer; Gerber, Bernd // Deutsches Aerzteblatt International;5/27/2011, Vol. 108 Issue 21, following p371 

    A bibliography on the subject of adjuvant therapy for women over age 65 with breast cancer is presented which includes the articles "Treatment of breast cancer in older women," by Bernardi D. and colleagues, "Acute toxicity of curative radiotherapy in elderly patients," by Huguenin P. and...

  • National Institute of Health Consensus Development Conference Statement: Adjuvant Therapy for....  // JNCI: Journal of the National Cancer Institute;7/14/2001, Vol. 93 Issue 13, p979 

    Focuses on the conference statement on the use of adjuvant therapy for breast cancer in the United States. Aims of the National Institutes of Health Consensus Development conference; Availability of adjuvant therapy to women with tumors expressing hormone receptor protein; Inclusion of...

  • A safer substitute for tamoxifen? Polak, Monika // GP: General Practitioner;6/3/2002, p57 

    Presents the drug anastrozole as alternative medicine for breast cancer treatment in Great Britain. Reduction of side-effects; Cost of anastrozole treatment; Differences between anastrozole and tamoxifen; Potential of causing osteoporosis.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics